WPRIM Management System> DCMS> Nuclear Medicine and Molecular Imaging> 2009> 43> 6

Volume: 43 Issue: 6

1. Clinical Application of (18)F-FDG PET in Multiple Myeloma. Page:509—512
2. Camurati-Engelmann's Disease on (99m)Tc-MDP Bone Scan. Page:596—599
3. Juvenile Dermatomyositis Diagnosed by (99m)Tc-HDP Three-phase Bone Scintigraphy. Page:592—595
4. (99m)Tc-HDP Bone Scintigraphy Finding of Metastatic Renal Cell Carcinoma Bone Lesion Changed from Hot to Cold Lesion: Comparing with (18)F-FDG PET/CT. Page:588—591
5. A Discrepancy between (131)I-Metaiodobenzylguanidine ((131)I-MIBG) Scintigraphy and (18)F-FDG PET/CT after (131)I-MIBG Therapy in a Patient with Recurred Malignant Pheochromocytoma. Page:582—587
6. F-18 FDG PET/CT Finding in Solid Pseudo-papillary Tumor of the Pancreas 6 years After Initial Diagnosis. Page:577—581
7. Clinical Usefulness between High Dose Radioiodine Therapy and Helicobacter Pylori Infection after Total Thyroidectomy due to Well Differentiated Thyroid Cancer. Page:572—576
8. The Clinical Utility of Rectal Gas Distension F-18 FDG PET/CT. Page:565—571
9. Comparison between FDG Uptake and Pathologic or Immunohistochemical Parametersin Pre-operative PET/CT Scan of Patient with Primary Colorectal Cancer. Page:557—564
10. (18)F-FDG PET/CT for the Preoperative Diagnosis of Papillary Thyroid Microcarcinoma: The Value of Dual Time Point Imaging. Page:543—556
11. Pilot Study for the Prediction of Response to Radiotherapy Using (18)FFluorothymidine PET in Nasopharyngeal Cancer: Comparison with (18)FFDG PET. Page:535—542
12. Detection of Cancer with PET and PET/CT in Asymptomatic Volunteers. Page:526—534
13. Clinical Significance of Myocardial Uptake on F-18 FDG PET/CT Performed in Oncologic Patients. Page:519—525
14. Added Value of 3D Cardiac SPECT/CTA Fusion Imaging in Patients with Reversible Perfusion Defect on Myocardial Perfusion SPECT. Page:513—518